Guangdong, China

Dongyun Wu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Guangdong, CN (2021 - 2022)
  • Shenzhen, CN (2022)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Dongyun Wu

Introduction

Dongyun Wu is a prominent inventor based in Guangdong, China, known for his significant contributions to cancer treatment methodologies. With a total of 5 patents, his work focuses on harnessing the power of activated T cells for innovative cancer therapies.

Latest Patents

One of his latest patents is titled "Methods of cancer treatment using activated T cells." This invention outlines a method for treating cancer in individuals by utilizing activated T cells or peripheral blood mononuclear cells (PBMCs) induced by antigen-presenting cells, such as dendritic cells, loaded with various tumor antigen peptides. The method may also involve administering these antigen-presenting cells to the individual. Furthermore, it includes precision therapy methods tailored to the individual, utilizing neoantigen peptides or based on the mutation load in the tumor. Additional aspects of the patent cover methods for preparing activated T cells, monitoring treatment, and cloning tumor-specific T cell receptors. Another notable patent is "Multiple antigen specific cell therapy methods," which details the preparation of activated T cells through co-culturing with dendritic cells loaded with tumor antigen peptides. This patent also encompasses methods for treating cancer using these activated T cells, along with pharmaceutical compositions and kits for cell-based cancer immunotherapy.

Career Highlights

Dongyun Wu has worked with notable companies in the biotech sector, including Syz Cell Therapy Co. and Hryz (Shenzhen) Biotech Co. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.

Collaborations

Throughout his career, Dongyun Wu has collaborated with esteemed colleagues, including Xiangjun Zhou and Yanyan Han. These partnerships have further enhanced his research and development efforts in the field of cancer treatment.

Conclusion

Dongyun Wu's innovative approaches to cancer treatment through activated T cells represent a significant advancement in the field of immunotherapy. His contributions continue to pave the way for more effective cancer treatments, showcasing the potential of personalized medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…